Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Journal of Immunological Methods
|
August 13, 2018
Bead-extraction and heat-dissociation (BEHD): A novel way to overcome drug and matrix interference in immunogenicity testing
Weifeng Xu, Michael Sank, Jennifer Cummings, et al.
The Journal of Rheumatology
|
December 1, 2007
Evaluation of immunogenicity of the T cell costimulation modulator abatacept in patients treated for rheumatoid arthritis
Helen G Haggerty, Mark A Abbott, Timothy P Reilly, et al.
Bioanalysis
|
June 4, 2015
Anti-PEG antibody bioanalysis: a clinical case study with PEG-IFN-λ-1a and PEG-IFN-α2a in naive patients
Heather Myler, Matthew W Hruska, Subasree Srinivasan, et al.
Analytical Chemistry
|
February 11, 2014
Innovative use of LC-MS/MS for simultaneous quantitation of neutralizing antibody, residual drug, and human immunoglobulin G in immunogenicity assay development
Hao Jiang, Weifeng Xu, Craig A Titsch, et al.
Clinical Pharmacology and Therapeutics
|
November 20, 2023
An IQ Consortium Perspective on Best Practices for Bioanalytical and Immunogenicity Assessment Aspects of CAR-T and TCR-T Cellular Therapies Development
Jochem Gokemeijer, Nanda Balasubramanian, Ken Ogasawara, et al.
The AAPS Journal
|
July 1, 2026
Updated Recommendations for the Bioanalysis of Antibody-Drug Conjugates (ADC) from the ADC working group of the AAPS Bioanalytical Community
Jim X Shen, Robert Dodge, Shoshana Oberstein, et al.
The AAPS Journal
|
July 8, 2023
Neutralizing Antibody Validation Testing and Reporting Harmonization
Heather Myler, João Pedras-Vasconcelos, Todd Lester, et al.
Bioanalysis
|
November 30, 2018
2018 White Paper on Recent Issues in Bioanalysis: focus on immunogenicity assays by hybrid LBA/LCMS and regulatory feedback (Part 2 - PK, PD & ADA assays by hybrid LBA/LCMS & regulatory agencies' inputs on bioanalysis, biomarkers and immunogenicity)
Hendrik Neubert, Timothy Olah, Anita Lee, et al.
Bioanalysis
|
November 30, 2018
2018 White Paper on Recent Issues in Bioanalysis: 'A global bioanalytical community perspective on last decade of incurred samples reanalysis (ISR)' (Part 1 - small molecule regulated bioanalysis, small molecule biomarkers, peptides & oligonucleotide bioanalysis)
Jan Welink, Yuanxin Xu, Eric Yang, et al.
Bioanalysis
|
May 17, 2022
2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability & Cut Point Appropriateness (<u>Part 3</u> - Recommendations on Gene Therapy, Cell Therapy, Vaccine Assays; Immunogenicity of Biotherapeutics and Novel Modalities; Integrated Summary of Immunogenicity Harmonization)
Lina Loo, Shannon Harris, Mark Milton, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Journal of Immunological Methods
|
August 13, 2018
Bead-extraction and heat-dissociation (BEHD): A novel way to overcome drug and matrix interference in immunogenicity testing
Weifeng Xu, Michael Sank, Jennifer Cummings, et al.
The Journal of Rheumatology
|
December 1, 2007
Evaluation of immunogenicity of the T cell costimulation modulator abatacept in patients treated for rheumatoid arthritis
Helen G Haggerty, Mark A Abbott, Timothy P Reilly, et al.
Bioanalysis
|
June 4, 2015
Anti-PEG antibody bioanalysis: a clinical case study with PEG-IFN-λ-1a and PEG-IFN-α2a in naive patients
Heather Myler, Matthew W Hruska, Subasree Srinivasan, et al.
Analytical Chemistry
|
February 11, 2014
Innovative use of LC-MS/MS for simultaneous quantitation of neutralizing antibody, residual drug, and human immunoglobulin G in immunogenicity assay development
Hao Jiang, Weifeng Xu, Craig A Titsch, et al.
Clinical Pharmacology and Therapeutics
|
November 20, 2023
An IQ Consortium Perspective on Best Practices for Bioanalytical and Immunogenicity Assessment Aspects of CAR-T and TCR-T Cellular Therapies Development
Jochem Gokemeijer, Nanda Balasubramanian, Ken Ogasawara, et al.
The AAPS Journal
|
July 1, 2026
Updated Recommendations for the Bioanalysis of Antibody-Drug Conjugates (ADC) from the ADC working group of the AAPS Bioanalytical Community
Jim X Shen, Robert Dodge, Shoshana Oberstein, et al.
The AAPS Journal
|
July 8, 2023
Neutralizing Antibody Validation Testing and Reporting Harmonization
Heather Myler, João Pedras-Vasconcelos, Todd Lester, et al.
Bioanalysis
|
November 30, 2018
2018 White Paper on Recent Issues in Bioanalysis: focus on immunogenicity assays by hybrid LBA/LCMS and regulatory feedback (Part 2 - PK, PD & ADA assays by hybrid LBA/LCMS & regulatory agencies' inputs on bioanalysis, biomarkers and immunogenicity)
Hendrik Neubert, Timothy Olah, Anita Lee, et al.
Bioanalysis
|
November 30, 2018
2018 White Paper on Recent Issues in Bioanalysis: 'A global bioanalytical community perspective on last decade of incurred samples reanalysis (ISR)' (Part 1 - small molecule regulated bioanalysis, small molecule biomarkers, peptides & oligonucleotide bioanalysis)
Jan Welink, Yuanxin Xu, Eric Yang, et al.
Bioanalysis
|
May 17, 2022
2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability & Cut Point Appropriateness (<u>Part 3</u> - Recommendations on Gene Therapy, Cell Therapy, Vaccine Assays; Immunogenicity of Biotherapeutics and Novel Modalities; Integrated Summary of Immunogenicity Harmonization)
Lina Loo, Shannon Harris, Mark Milton, et al.
Page
of 2